215 related articles for article (PubMed ID: 9605927)
1. Requirements for repression of retinoid X receptor by the oncoprotein P75gag-v-erbA and the thyroid hormone receptors.
Wahlström GM; Vennström B
Mol Endocrinol; 1998 May; 12(5):645-53. PubMed ID: 9605927
[TBL] [Abstract][Full Text] [Related]
2. The oncoprotein P75gag-v-erbA represses thyroid hormone induced transcription only via response elements containing palindromic half-sites.
Wahlström GM; Harbers M; Vennström B
Oncogene; 1996 Aug; 13(4):843-52. PubMed ID: 8761306
[TBL] [Abstract][Full Text] [Related]
3. Dimerization of v-erbA on inverted repeats.
Zubkova I; Subauste JS
Biochem Biophys Res Commun; 2002 May; 294(1):35-41. PubMed ID: 12054736
[TBL] [Abstract][Full Text] [Related]
4. V-erbA requires auxiliary proteins for dominant negative activity.
Hermann T; Hoffmann B; Piedrafita FJ; Zhang XK; Pfahl M
Oncogene; 1993 Jan; 8(1):55-65. PubMed ID: 8093812
[TBL] [Abstract][Full Text] [Related]
5. Identification of DNA binding sites for the V-erbA oncoprotein, the viral homolog to thyroid hormone receptor alpha.
Harbers M; Wahlström GM; Vennström B
J Steroid Biochem Mol Biol; 1998 Nov; 67(3):181-91. PubMed ID: 9879977
[TBL] [Abstract][Full Text] [Related]
6. A choice between transcriptional enhancement and repression by the v-erbA oncoprotein governed by one nucleotide in a thyroid hormone responsive half site.
Andersson ML; Vennström B
Oncogene; 2000 Jul; 19(32):3563-9. PubMed ID: 10951561
[TBL] [Abstract][Full Text] [Related]
7. Modulation of thyroid hormone action by mutant thyroid hormone receptors, c-erbA alpha 2 and peroxisome proliferator-activated receptor: evidence for different mechanisms of inhibition.
Meier-Heusler SC; Zhu X; Juge-Aubry C; Pernin A; Burger AG; Cheng SY; Meier CA
Mol Cell Endocrinol; 1995 Jan; 107(1):55-66. PubMed ID: 7796935
[TBL] [Abstract][Full Text] [Related]
8. Retinoid X receptor and c-cerbA/thyroid hormone receptor regulate erythroid cell growth and differentiation.
Bartůnĕk P; Zenke M
Mol Endocrinol; 1998 Sep; 12(9):1269-79. PubMed ID: 9731697
[TBL] [Abstract][Full Text] [Related]
9. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
Raval-Pandya M; Freedman LP; Li H; Christakos S
Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of transformation by v-ErbA: substitution for steroid hormone receptor function in self renewal induction.
Bauer A; Ulrich E; Andersson M; Beug H; von Lindern M
Oncogene; 1997 Aug; 15(6):701-15. PubMed ID: 9264411
[TBL] [Abstract][Full Text] [Related]
11. Two silencing sub-domains of v-erbA synergize with each other, but not with RXR.
Martin B; Renkawitz R; Muller M
Nucleic Acids Res; 1994 Nov; 22(23):4898-905. PubMed ID: 7800478
[TBL] [Abstract][Full Text] [Related]
12. Protein-protein interaction domains and the heterodimerization of thyroid hormone receptor variant alpha2 with retinoid X receptors.
Wu Y; Yang YZ; Koenig RJ
Mol Endocrinol; 1998 Oct; 12(10):1542-50. PubMed ID: 9773977
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the functional role of steroid receptor coactivator-1 in ligand-induced transactivation by thyroid hormone receptor.
Jeyakumar M; Tanen MR; Bagchi MK
Mol Endocrinol; 1997 Jun; 11(6):755-67. PubMed ID: 9171239
[TBL] [Abstract][Full Text] [Related]
14. Constitutive transactivation by the thyroid hormone receptor and a novel pattern of activity of its oncogenic homolog v-ErbA in Xenopus oocytes.
Nagl SB; Nelson CC; Romaniuk PJ; Allison LA
Mol Endocrinol; 1995 Nov; 9(11):1522-32. PubMed ID: 8584030
[TBL] [Abstract][Full Text] [Related]
15. The v-ErbA oncoprotein quenches the activity of an erythroid-specific enhancer.
Braliou GG; Ciana P; Klaassen W; Gandrillon O; Stunnenberg HG
Oncogene; 2001 Feb; 20(7):775-87. PubMed ID: 11314012
[TBL] [Abstract][Full Text] [Related]
16. Heterodimerization among thyroid hormone receptor, retinoic acid receptor, retinoid X receptor, chicken ovalbumin upstream promoter transcription factor, and an endogenous liver protein.
Berrodin TJ; Marks MS; Ozato K; Linney E; Lazar MA
Mol Endocrinol; 1992 Sep; 6(9):1468-78. PubMed ID: 1331778
[TBL] [Abstract][Full Text] [Related]
17. Constitutive expression of the orphan receptor, Rev-erbA alpha, inhibits muscle differentiation and abrogates the expression of the myoD gene family.
Downes M; Carozzi AJ; Muscat GE
Mol Endocrinol; 1995 Dec; 9(12):1666-78. PubMed ID: 8614403
[TBL] [Abstract][Full Text] [Related]
18. Factors influencing nuclear receptors in transcriptional repression.
Burcin M; Köhne AC; Runge D; Steiner C; Renkawitz R
Semin Cancer Biol; 1994 Oct; 5(5):337-46. PubMed ID: 7849262
[TBL] [Abstract][Full Text] [Related]
19. The erbA oncogene represses the actions of both retinoid X and retinoid A receptors but does so by distinct mechanisms.
Chen HW; Privalsky ML
Mol Cell Biol; 1993 Oct; 13(10):5970-80. PubMed ID: 8105369
[TBL] [Abstract][Full Text] [Related]
20. Sequences required for the transition from monomeric to homodimeric forms of thyroid hormone receptor alpha and v-erbA.
Zubkova I; Subauste JS
Mol Cell Endocrinol; 2003 Jan; 199(1-2):61-72. PubMed ID: 12581880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
